0001562180-20-005657.txt : 20200825 0001562180-20-005657.hdr.sgml : 20200825 20200825191921 ACCESSION NUMBER: 0001562180-20-005657 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200824 FILED AS OF DATE: 20200825 DATE AS OF CHANGE: 20200825 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Diamond Andrew S CENTRAL INDEX KEY: 0001800611 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39203 FILM NUMBER: 201133860 MAIL ADDRESS: STREET 1: C/O 1LIFE HEALTHCARE, INC. STREET 2: ONE EMBARCADERO CENTER, SUITE 1900 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: 1Life Healthcare Inc CENTRAL INDEX KEY: 0001404123 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 760707204 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE EMBARCADERO CENTER, SUITE 1900 CITY: San Francisco STATE: CA ZIP: 94111 BUSINESS PHONE: (415) 814-0927 MAIL ADDRESS: STREET 1: ONE EMBARCADERO CENTER, SUITE 1900 CITY: San Francisco STATE: CA ZIP: 94111 FORMER COMPANY: FORMER CONFORMED NAME: 1life Healthcare Inc DATE OF NAME CHANGE: 20070621 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2020-08-24 false 0001404123 1Life Healthcare Inc ONEM 0001800611 Diamond Andrew S C/O 1LIFE HEALTHCARE, INC. ONE EMBARCADERO CENTER, SUITE 1900 SAN FRANCISCO CA 94111 false true false false Chief Medical Officer Common Stock 2020-08-24 4 M false 15677.00 4.37 A 124651.00 D Common Stock 2020-08-24 4 S false 15677.00 29.9931 D 108974.00 D Stock Option (Right to Buy) 4.37 2020-08-24 4 M false 15677.00 0.00 D 2019-10-01 2025-09-30 Common Stock 15677.00 27922.00 D These trades were made pursuant to a Rule 10b5-1 trading plan with shares of common stock received upon concurrent exercises of stock options. This transaction was executed in multiple trades at prices ranging from $29.99 to $30.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ Matthew B. Hemington, Attorney-in-Fact for Andrew S. Diamond 2020-08-25